Latest Clinical - Phase News

[Articles] Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomiseREGN727 was well tolerated and achieved substantial further LDL-C reduction in patients with heterozygous familial hypercholesterolaemia and elevated LDL-C treated with high-dose statins, with or without ezetimibe. REGN727 has the potential to provid...

New Wellness Team Approach Improves Diabetes Outcomes while Lowering Medication Costs An integrated wellness team approach to diabetes care is helping patients lower their prescription costs and improve their condition, according to research presented today at the American Association of Clinical Endocrinologists’ (AACE) 21st Annual Scientific & Clinical Congress

Regular Aerobic Exercise Improves Vascular Reactivity for Patients at Risk of Developing DiabetesPre-diabetic patients who engage in regular aerobic exercise improve their vascular reactivity to nearly normal levels, even if no weight loss is achieved, according to research presented today at the American Association of Clinical Endocrinologists (AACE) 21st Annual Meeting & Clinica

Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The LancetPARIS and TARRYTOWN, New York, May 26, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase 2 trial of SAR236553/REGN727 (Study 1003, NTC01266876) in patients with heterozygous familial hypercholesterolemia (heFH). SAR236553/REGN727 is a subcutaneously administered, fully-human antibod...

Tranzyme Pharma and Norgine Announce Top-Line Data From ULISES 008, the Second of Two Phase 3 ...

Sanofi to Start China Clinical Trial of Cancer Drug In-licensed from SIBSSanofi hopes to begin a Phase I clinical trial in China next year of a novel drug that targets liver cancer. The molecule inhibits the slit-robo signaling path that controls tumor vasculature and tumor growth, a discovery made by researchers at th...

News digest – clinical trials, bowel cancer screening, coffee and cancer, and moreSunday was International Clinical Trials Day. To mark the occasion, Gareth Griffiths, Scientific Director of our Wales Cancer Trials Unit, wrote us an article about the world-class clinical trials being carried out there. Nearly one in five cancer pa...

Clinical Support Services Develops MTM Program Assessment GuideCMS has strengthened MTM program rules and regulations, so Medicare plans are urged to take a hard look at their offerings to ensure their compliance and success. Buffalo, NY (PRWEB) May 26, 2012 New Medication Therapy Management (MTM) program requirements outlined by the Centers for Medicare & Medicaid Services (CMS) will make delivering a successful and compliant MTM program more challengin...

Apollo Group's White Dental Clinic offers high end clinical─cosmetic procedures to save natural teethWhite Dental Clinic, an Apollo Group initiative, is offering Micro Dentistry and Snap─on─Smile which would prove to be economical in the long run for patients.

[Articles] Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trialIntravenous magnesium sulphate does not improve clinical outcome after aneurysmal subarachnoid haemorrhage, therefore routine administration of magnesium cannot be recommended.

Breast Cancer Risk Associated With Sex Hormones Reduced By Losing WeightThe Journal of Clinical Oncology has published a study online which reveals that even a moderate amount of weight loss can considerably decrease levels of circulating estrogens that are linked to a higher risk of breast cancer. Anne McTiernan, M.D.,...

Clinilabs Opens Phase I Unit in New JerseyClinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, announced Thursday that they have opened a second Phase I unit in Southern New Jersey.

ODAC meeting to discuss RCC imagingFDA's Oncologic Drugs Advisory Committee (ODAC) will meet on July 25 to discuss the extent of useful clinical information provided by an imaging test for clear cell renal cell carcinoma (RCC) before surgery. FDA will also review the development strat...

Short Course of Drug Fails in Vent-Associated Pneumonia (CME/CE)SAN FRANCISCO (MedPage Today) -- A short course of high-dose doripenem (Doribax) for ventilator-associated pneumonia did more harm than good, and a clinical trial testing the approach was stopped early, a researcher said here.

Center for Ambulatory Surgery Selects ProVation® Medical Software for Gastroenterology Procedure Documentation and CodingWolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that the Center for Ambulatory Surgery has selected its ProVation® Medical Software for gastroenterology procedure documentation and coding. Located in West Seneca, NY, the Center for Ambulatory Surgery provides outpat...

Advanced Biological Laboratories' DeepChek® and ViroScore® Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic UseAdvanced Biological Laboratories (ABL) announced today that DeepChek® and ViroScore® Suite clinical genotyping solutions are now CE-IVD (In Vitro Diagnostics) approved for commercial use in Europe and other countries that recognise CE certification. This approval is further validating the use of our next generation sequencing (NGS) downstream an...

Summit Corporation PLC : Summit Announces Initiation of Phase 1 Trial for the Treatment of ...

Postprostatectomy Test Predicts Risk for Clinical RecurrenceAn ultrasensitive immuno-PCR assay provides prognostic data after radical prostatectomy. Medscape Medical News

Drugmakers pledge transparency to tackle credibility problem in journalsEight leading pharmaceutical companies have approved 10 recommendations aimed at improving transparency to address what they call a “credibility gap” that faces industry-funded clinical research. (American Medical News)

Cancer Imaging In Clear Cell Renal Carcinoma Gets ODAC Attention As Pipeline FillsFDA’s Oncologic Drugs Advisory Committee will examine the extent (if any) to which the pre-surgical identification of clear cell carcinoma of the kidney using an imaging test provides useful clinical information. ASCO abstracts show considerable re...

ImmunoCellular to list on NYSE:MKTBiotech firm ImmunoCellular Therapeutics (OTC:IMUC) reported that its common stock will now be listed on the New York stock Exchange, as the company seeks a broader investor base.The California-based company develops novel therapies to fight against...

Lilly reports positive data in phase II diabetes study of dulaglutideSummary not available

Sanofi To Test Liver-Cancer Drug In China, South Korea Next YearSanofi plans to conduct clinical trials in China and South Korea next year for a drug to treat liver cancer by cutting off nourishment to a protein that helps it spread.

XenoPort submits IND application to commence XP23829 clinical studiesXenoPort has submitted an Investigational New Drug (IND) application to the FDA to commence XP23829 clinical studies as a potential treatment for relapsing-remitting multiple sclerosis (RRMS).

REGISTRAT-MAPI Names Vice President, Clinical Operations EUREGISTRAT-MAPI is pleased to announce that Nathalie Doize has joined the company as Vice President, Clinical Operations for REGISTRAT-MAPI EU. (PRWEB) May 25, 2012 Working as a key member of the organization’s Executive Leadership, Nathalie will assume responsibilities for clinical operations in Europe and affiliated territories. She will be responsible for the strategic development and functio...

0 1 2 3 4 ›»

buy Clinical - Phase market research data and corporate reports now Advertisement